Warner Chilcott announced that the FDA has approved Lo Loestrin FE (norethindrone acetate and ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate tablets) for the prevention of ...

Lo Loestrin Fe (norethindrone acetate/ethinyl estradiol/ferrous fumarate) has potential interactions with other medications and some supplements. For example, Lo Loestrin Fe can interact with ...

ARDEE, Ireland The Food and Drug Administration has approved a new contraceptive from Warner Chilcott, the drug maker said Friday. The company said it plans to launch Lo Loestrin Fe (norethindrone ...

ARDEE, Ireland, Oct 22, 2010 /PRNewswire via COMTEX News Network/ -- Warner Chilcott plc (Nasdaq: WCRX) today announced that the United States Food and Drug Administration (FDA) has approved LO ...

NEW YORK — Generic drug maker Lupin is seeking approval for a generic version of a contraceptive made by Warner Chilcott, according to published reports. Reuters reported that Lupin had applied for ...

October 25, 2010 — The US Food and Drug Administration (FDA) has approved a prepackaged regimen of norethindrone acetate/ethinyl estradiol tablets, ethinyl estradiol tablets, and ferrous fumarate ...

Amneal announced the future launch of Lomedia 24 Fe (norethindrone acetate/ethinyl estradiol and ferrous fumarate), the generic version of Warner Chilcott’s Loestrin 24 Fe. RELATED: Ob/Gyn Resource ...

DUBLIN, Oct. 23, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States ...

DUBLIN, Jan. 17, 2014 /PRNewswire/ --Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the District of New Jersey found United States Patent No. 7,704,984 (the '984 ...